Header Logo

Connection

SUSAN HILSENBECK to Tumor Burden

Back to Details
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Tumor Burden.
SUSAN HILSENBECK
Connection Strength
0.023
Tumor Burden
  1. Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model. PLoS One. 2012; 7(8):e30207.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.